The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | COM | 00032Q104 | 12,649,910 | 1,849,402 | SH | SOLE | 1,849,402 | 0 | 0 | ||
ACLARIS THERAPEUTICS | COM | 00461U105 | 1,261,946 | 121,692 | SH | SOLE | 121,692 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 1,398,766 | 44,689 | SH | SOLE | 44,689 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 27,110,996 | 297,596 | SH | SOLE | 297,596 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 4,898,127 | 12,568 | SH | SOLE | 12,568 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS INC | COM | 04280A100 | 980,650 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 878,000 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 4,151,098 | 122,343 | SH | SOLE | 122,343 | 0 | 0 | ||
CLENE INC | COMMON STOCK | 185634102 | 3,731,520 | 4,240,846 | SH | SOLE | 4,240,846 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC. COMMON STOCK | COM | 23257D103 | 4,708,500 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 6,193,800 | 139,500 | SH | SOLE | 139,500 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 821,250 | 73,000 | SH | SOLE | 73,000 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 2,132,845 | 104,500 | SH | SOLE | 104,500 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 3,323,400 | 382,000 | SH | SOLE | 382,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 2,904,884 | 244,828 | SH | SOLE | 244,828 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 1,084,311 | 63,078 | SH | SOLE | 63,078 | 0 | 0 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 3,660,480 | 558,000 | SH | SOLE | 558,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 2,689,092 | 141,755 | SH | SOLE | 141,755 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 5,171,400 | 131,454 | SH | SOLE | 131,454 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 541,800 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
KURA ONCOLOGY INC. COMMON STOCK | COM | 50127T109 | 7,502,468 | 709,118 | SH | SOLE | 709,118 | 0 | 0 | ||
MORPHIC HOLDING INC | COM | 61775R105 | 1,003,275 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/2027 | 67080N119 | 15,023 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 955,500 | 105,814 | SH | SOLE | 105,814 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 4,887,500 | 4,250,000 | SH | SOLE | 4,250,000 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 739,332 | 373,400 | SH | SOLE | 373,400 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 6,084,075 | 306,194 | SH | SOLE | 306,194 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHARES | G76279101 | 2,217,600 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 633,054 | 198,139 | SH | SOLE | 198,139 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 6,275,672 | 299,841 | SH | SOLE | 299,841 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 8,487,500 | 970,000 | SH | SOLE | 970,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 6,100,970 | 122,166 | SH | SOLE | 122,166 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 4,832,030 | 147,318 | SH | SOLE | 147,318 | 0 | 0 | ||
VERASTEM INC | COM NEW | 92337C203 | 2,232,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 5,345,780 | 224,707 | SH | SOLE | 224,707 | 0 | 0 |